Sulfapyridine is a sulfonamide antibiotic with antibacterial and anti-inflammatory activities.It is an antibiotic and is mostly used in treating rheumatoid arthritis.
This report contains market size and forecasts of Sulfapyridine in global, including the following market information:
Global Sulfapyridine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sulfapyridine Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Sulfapyridine companies in 2021 (%)
The global Sulfapyridine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sulfapyridine include Abcam, United States Biological, Merck, TCI, Santa Cruz Biotechnology, Spectrum Chemical, LGC, Cayman Chemical and Biosynth Carbosynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sulfapyridine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sulfapyridine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sulfapyridine Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Sulfapyridine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sulfapyridine Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Sulfapyridine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Sulfapyridine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sulfapyridine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sulfapyridine revenues share in global market, 2021 (%)
Key companies Sulfapyridine sales in global market, 2017-2022 (Estimated), (MT)
Key companies Sulfapyridine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
United States Biological
Merck
TCI
Santa Cruz Biotechnology
Spectrum Chemical
LGC
Cayman Chemical
Biosynth Carbosynth
AbMole
KareBay Biochem
J&K Scientific